Literature DB >> 15015064

Pseudotumor cerebri following cyclosporine A treatment in a boy with tubulointerstitial nephritis associated with uveitis.

Rainer Büscher1, Oliver Vij, Tobias Hudde, Peter F Hoyer, Udo Vester.   

Abstract

An 11-year-old boy with recurrent nephritis due to tubulointerstitial nephritis associated with uveitis (TINU syndrome) was treated with cyclosporin A (CSA) to induce sustained remission. CSA was introduced as a steroid-sparing drug because of extreme obesity (body mass index 32 kg/m(2)). Although the boy did not complain of any clinical symptoms, eye inspection after 7 months revealed bilateral disk edema with retinal bleeding and the patient developed cerebrospinal hypertension. Pseudotumor cerebri was diagnosed by measuring the intracranial pressure (31 cm H(2)O) and normal computer tomography and brain magnetic resonance imaging. Cessation of CSA therapy and treatment with mycophenolate mofetil led to resolution within 12 weeks.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15015064     DOI: 10.1007/s00467-004-1429-9

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  16 in total

Review 1.  Cyclosporine.

Authors:  B D Kahan
Journal:  N Engl J Med       Date:  1989-12-21       Impact factor: 91.245

2.  Rescue therapy with mycophenolate mofetil in refractory uveitis.

Authors:  D J Kilmartin; J V Forrester; A D Dick
Journal:  Lancet       Date:  1998-07-04       Impact factor: 79.321

Review 3.  Neurotoxicity of calcineurin inhibitors: impact and clinical management.

Authors:  W O Bechstein
Journal:  Transpl Int       Date:  2000       Impact factor: 3.782

4.  [Immunosuppressive therapy with mycophenolate mofetil (CellCept) in treatment of uveitis].

Authors:  M Zierhut; N Stübiger; W Aboalchamat; H Landenberger; A A Bialasiewicz; K Engelmann
Journal:  Ophthalmologe       Date:  2001-07       Impact factor: 1.059

Review 5.  Health consequences of obesity in youth: childhood predictors of adult disease.

Authors:  W H Dietz
Journal:  Pediatrics       Date:  1998-03       Impact factor: 7.124

6.  Idiopathic acute interstitial nephritis: characterization of the infiltrating cells in the renal interstitium as T helper lymphocytes.

Authors:  R Pamukcu; V Moorthy; J R Singer; R Hong; D P Simpson
Journal:  Am J Kidney Dis       Date:  1984-07       Impact factor: 8.860

7.  Complications of cyclosporine-prednisone immunosuppression in 402 renal allograft recipients exclusively followed at a single center for from one to five years.

Authors:  B D Kahan; S M Flechner; M I Lorber; D Golden; S Conley; C T Van Buren
Journal:  Transplantation       Date:  1987-02       Impact factor: 4.939

8.  Pseudotumor cerebri associated with cyclosporine use.

Authors:  O A Cruz; S G Fogg; G Roper-Hall
Journal:  Am J Ophthalmol       Date:  1996-09       Impact factor: 5.258

9.  Cyclosporin A toxicity of the renal allograft--a late complication and potentially reversible.

Authors:  Claudia Sommerer; Okaf Hergesell; Anna-Maria Nahm; Vedat Schwenger; Rüdiger Waldherr; Konrad Andrassy; Martin Zeier
Journal:  Nephron       Date:  2002-10       Impact factor: 2.847

10.  [Adult uveitis: apropos of 1 case with acute idiopathic interstitial nephritis].

Authors:  F Ben Hamida; M A Kheder; F el Younsi; E Abderrahim; F Ben Moussa; R Goucha; H Ben Maiz
Journal:  Nephrologie       Date:  1995
View more
  2 in total

1.  Tubulointerstitial nephritis and uveitis syndrome associated with hyperthyroidism.

Authors:  Itaru Ebihara; Kouichi Hirayama; Joichi Usui; Masanori Seki; Fujiko Higuchi; Takaaki Oteki; Masaki Kobayashi; Kunihiro Yamagata
Journal:  Clin Exp Nephrol       Date:  2006-09       Impact factor: 2.801

2.  Re-recognition of Age-dependent Reference Range for the Serum Creatinine Level in Teenagers - A Case of Slowly Progressive Tubulointerstitial Nephritis which Occurred in an Adolescent.

Authors:  Hiroyuki Ono; Kojiro Nagai; Eriko Shibata; Motokazu Matsuura; Seiji Kishi; Taizo Inagaki; Masanori Minato; Sakiya Yoshimoto; Sayo Ueda; Fumiaki Obata; Kenji Nishimura; Masanori Tamaki; Fumi Kishi; Taichi Murakami; Hideharu Abe; Yukiko Kinoshita; Maki Urushihara; Shoji Kagami; Toshio Doi
Journal:  Intern Med       Date:  2017-08-01       Impact factor: 1.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.